Grant: Engage Grants Program
Institut national de la recherche scientifique
$25,000.00
Generating fluorescent and luminescent enterobacteria for use in molecule screening to identify adherence and cell invasion inhibitors.
FY 2014-15
Summary
Bacterial pathogens continue to be a major problem to both human and animal health worldwide. Increased andmultiple resistances to antibiotics have in many cases rendered treatment of certain bacterial infectionsdifficult. As fewer and fewer of the antibiotics in current use in either human or veterinary medicine areefficacious, there is a growing need to develop alternative approaches to traditional antimicrobials. The purposeof this research is to develop tools to generate fluorescent-tagged or bioluminescent strains of bacteria. Bygenerating these tools, this will allow more simple testing of the capacity of novel molecules to inhibitadherence or invasion of cells and also determine whether treatment with such agents can prevent colonizationin animal models. Such approaches will facilitate determination of new molecules that could be of use toreduce the presence of certain food-borne pathogens in livestock and poultry. In addition, the use of suchtagged bacterial pathogens may also lead to selection of the best molecules that could offer novel means ofreducing infectious disease without the use of traditional antibiotics, which have the potential to generatemulti-resistant bacterial pathogens that are a threat to both animal health and public health. The underlyingproblem faced by the partnering company Vertex is that the testing of a variety of molecules for adherence orinvasion inhibition using conventional methods such as viable culture following cell interaction assays islabour intensive and inconvenient. The generation of bacterial strains containing fluorescent or luminescentmarkers will lead to a means of more high throughput methods of screening inhibitors as well as directvisualisation of bacterial-host interactions with or without the addition of these inhibitors. Generation of suchstrains can therefore lead to more efficient and innovative means of screening for inhibitors in either cellinteraction models which may lead to the identification of lead compounds that would be promising forcommercial use.
Program
Engage Grants Program
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
468525-2014
Name nom
Dozois, Charles
Department département
INRS-Institut Armand-Frappier
Organization id
56
Institution établissement
Institut national de la recherche scientifique
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2014
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1552
Committee name en
Quebec Internal Decision Committee
Committee name fr
Comité de décision interne pour le Québec
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5201
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Bacteriology
Research subject fr
Bactériologie
Partie
1
Nb partie
1
Application title
Generating fluorescent and luminescent enterobacteria for use in molecule screening to identify
adherence and cell invasion inhibitors.
Keyword
NSERC
Application summary
Bacterial pathogens continue to be a major problem to both human and animal health worldwide. Increased andmultiple resistances to antibiotics have in many cases rendered treatment of certain bacterial infectionsdifficult. As fewer and fewer of the antibiotics in current use in either human or veterinary medicine areefficacious, there is a growing need to develop alternative approaches to traditional antimicrobials. The purposeof this research is to develop tools to generate fluorescent-tagged or bioluminescent strains of bacteria. Bygenerating these tools, this will allow more simple testing of the capacity of novel molecules to inhibitadherence or invasion of cells and also determine whether treatment with such agents can prevent colonizationin animal models. Such approaches will facilitate determination of new molecules that could be of use toreduce the presence of certain food-borne pathogens in livestock and poultry. In addition, the use of suchtagged bacterial pathogens may also lead to selection of the best molecules that could offer novel means ofreducing infectious disease without the use of traditional antibiotics, which have the potential to generatemulti-resistant bacterial pathogens that are a threat to both animal health and public health. The underlyingproblem faced by the partnering company Vertex is that the testing of a variety of molecules for adherence orinvasion inhibition using conventional methods such as viable culture following cell interaction assays islabour intensive and inconvenient. The generation of bacterial strains containing fluorescent or luminescentmarkers will lead to a means of more high throughput methods of screening inhibitors as well as directvisualisation of bacterial-host interactions with or without the addition of these inhibitors. Generation of suchstrains can therefore lead to more efficient and innovative means of screening for inhibitors in either cellinteraction models which may lead to the identification of lead compounds that would be promising forcommercial use.